"Energy-less technique" with mini-clips for recurrent laryngeal nerve lymph node dissection in prone thoracoscopic esophagectomy for esophageal cancer
H Saeki, Y Nakashima, K Hirose, S Sasaki, T Jogo… - The American Journal of …, 2017
Background Meticulous recurrent laryngeal nerve (RLN) lymph node dissection in
thoracoscopic esophagectomy for esophageal cancer often results in RLN paralysis.
Methods We had attempted to simply cut the vessels around RLN sharply with scissors
thoracoscopic esophagectomy for esophageal cancer often results in RLN paralysis.
Methods We had attempted to simply cut the vessels around RLN sharply with scissors
 |  |  |
[PDF] Study on the correlation between CD14 gene polymorphism and susceptibility to laryngeal cancer
J Su, J Cui, HT XUE, JH TIAN, JH ZHANG - European Review for Medical and …, 2017
Abstract.–OBJECTIVE: CD14 is the cell surface glycoprotein, which plays an important role
in the occurrence and development of tumors. This study was designed to assess the
association between CD14 SNPs and laryngeal cancer risk. PATIENTS AND METHODS:
in the occurrence and development of tumors. This study was designed to assess the
association between CD14 SNPs and laryngeal cancer risk. PATIENTS AND METHODS:
| | |
A Transparent Decision Support Tool in Screening for Laryngeal Disorders Using Voice and Query Data
J Minelga, A Verikas, E Vaiciukynas, A Gelzinis… - Applied Sciences, 2017
Abstract The aim of this study is a transparent tool for analysis of voice (sustained
phonation/a/) and query data capable of providing support in screening for laryngeal
disorders. In this work, screening is concerned with identification of potentially pathological
phonation/a/) and query data capable of providing support in screening for laryngeal
disorders. In this work, screening is concerned with identification of potentially pathological
| | |
[PDF] Annexin A2 is an independent prognostic biomarker for evaluating the malignant progression of laryngeal cancer
S Luo, C Xie, P Wu, J He, Y Tang, J Xu, S Zhao - Experimental and Therapeutic Medicine
Abstract Due to the lack of a definite diagnosis, a frequent recurrence rate and resistance to
chemotherapy or radiotherapy, the clinical outcome for patients with advanced laryngeal
cancer has not improved over the last decade. Annexin A2 is associated with the invasion
chemotherapy or radiotherapy, the clinical outcome for patients with advanced laryngeal
cancer has not improved over the last decade. Annexin A2 is associated with the invasion
| | |
This Google Scholar Alert is brought to you by Google.
Cancel alert
List my alerts
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου